Hyperoxaluria (Kidney Stones) Study
Hyperoxaluria (Kidney Stones) Trials in Phoenix
Centricity Research is currently participating in a hyperoxaluria study at our Phoenix, AZ location. Hyperoxaluria refers to a large amount of oxalate in the urine. Too much oxalate in the urine can lead to build-up of calcium oxalate crystals in the kidneys and urinary tract, which can lead to kidney stones, decreased kidney function, and even kidney failure. Advances in drug therapy are key to treating this disease in its early stages and preventing further damage.
Hyperoxaluria Clinical Trial
The objective of this study is to determine the efficacy and durability of an investigational drug against placebo in reducing urinary oxalate excretion in subjects with enteric hyperoxaluria. The study will also evaluate the long-term safety and treatment of the investigational drug against placebo on kidney stone disease progression and kidney function. You maybe be eligible to participate in this study if you:
- Are at least 18 years of age
- Have an underlying enteric disorder associated with malabsorption such as:
- malabsorptive bariatric surgery a minimum of 12 months prior to screening
- inflammatory bowel disease with small bowel involvement
- short bowel syndrome
- or other malabsorption syndrome with known or suspected history of history of calcium oxalate kidney stones or oxalate nephropathy
- Have had at least one documented kidney stone within 2 years prior to screening
Note: people who have had restrictive-only bariatric procedures (i.e vertical banded gastroplasty, adjustable gastric banding, sleeve gastrectomy) are not eligible to participate in the study.
Ready to Volunteer?
Volunteer today to see if you qualify for our hyperoxaluria study. Qualified volunteers may be compensated for time and travel.